The side effects associated with Equipoise® are generally mild. The structure of boldenone does allow it to convert into estrogen, but it does not have an extremely high affinity to do so. To try and quantify this we can look toward aromatization studies, which suggest that its rate of estrogen conversion should be roughly half that of testosterone’s. The tendency to develop a noticeable amount of water retention with this drug would therefore be slightly higher than that with Deca-DurabolinO (with an estimated 20°/a conversion), but much less than what would be expected with a stronger agent such as Testosterone. While one does still have a chance of encountering an estrogen related side effect as such when using this substance, it is not a common problem when taken at a moderate dosage level. Gynecomastia might theoretically become a concern, but is usually only heaved of with very sensitive individuals or (again) those venturing high in dosage. Should estrogenic effects become troublesome, the addition of Nolvadex® and/or Proviron® should of course make the cycle more tolerable. An antiaromatase such as Cytadren® or Arimidex® would be stronger options, however probably not indicated with a mild drug as such.
Also important is the property of equipoise for sale here and increase appetite. It will be useful for people who just can’t bring myself to eat much, and I still do not get calories. The boldenone can make women due to the fact that virilization from it are extremely rare. This drug has a wide range of use. It is used as in muscle mass and drying. Usually enough for beginners dosage of 400-600 mg per week, for experienced athletes – from 600 mg per week and higher.
Equipoise (Boldenone Undecylenate) is a structurally altered form of testosterone. It is a very slight change in an added double bond at the carbon one and two position. This double bond greatly reduces the hormone’s androgenicity, as well as estrogenic nature. It is then attached to the very large or long Undecylenate ester, which is responsible for controlling the release of the hormone once administered into the body. The Undecylenate ester allows for a peak release in Boldenone approximately 3-4 days after injection, with a slow continuous release of the hormone to follow for approximately 21 days.